Â. Correia

Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo

Christopher J. Silva, I. Zerr, W. Möbius, 2021, Movement disorders : official journal of the Movement Disorder Society.

Synaptic resilience is associated with maintained cognition during ageing

I. Deary, I. Deary, J. Tulloch, 2022, medRxiv.

The role of cellular prion protein in Alzheimer’s disease

Â. Correia, Ângela Correia, 2015 .

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias

I. Ferrer, I. Zerr, R. Sánchez-Valle, 2017, Molecular Neurodegeneration.

Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients

I. Zerr, F. Llorens, I. Ferrer, 2016, Aging.

Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie

I. Zerr, R. Bolea, J. Badiola, 2018, Molecular Neurobiology.

Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies

S. Hornemann, A. Aguzzi, I. Zerr, 2021, Science advances.

Detection of Prion Protein Seeding Activity in Tear Fluids.

I. Zerr, P. Lingor, M. Schmitz, 2023, The New England journal of medicine.

Ligands binding to the cellular prion protein induce its protective proteolytic release with therapeutic potential in neurodegenerative proteinopathies

S. Hornemann, A. Aguzzi, I. Zerr, 2021, bioRxiv.

Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie

I. Zerr, R. Bolea, J. Badiola, 2018, Molecular Neurobiology.